Full history for every metric is available with a Kvantra account
Key financial summary
Financials in EUR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | €m | 2,528 | 3,070 | 4,682 | 4,164 | 4,080 | 3,885 | 3,705 | 3,619 |
| Operating profit | €m | 103 | 54 | ||||||
| Net profit | €m | 161 | 189 | 344 | 87 | 108 | 76 | -56 | 135 |
| EPS reported | € | 3.86 | -2.85 | ||||||
| Operating cashflow per share | € | 9.65 | 24.18 | ||||||
| Capex per share | € | 11.66 | 12.31 | ||||||
| FCF per share | € | -2.01 | 11.87 | ||||||
| Free cash flow | €m | -40 | 231 | ||||||
| Net debt | €m | 805 | 825 | ||||||
| Book value equity | €m | 2,102 | 2,088 | ||||||
| Book value per share | € | 105.4 | 107.5 | ||||||
| Number of shares | m | 19.95 | 19.43 | ||||||
| DPS (TTM paid) | € | 2.00 | 2.00 |
Financial summary
Financials in EUR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 24.07 | - | ||||||
| P/B LTM | x | 0.88 | 0.61 | ||||||
| P/S LTM | x | 0.48 | 0.34 | ||||||
| P/FCF LTM | x | -46.19 | 5.49 | ||||||
| EV/EBITDA LTM | x | 8.59 | 6.12 | ||||||
| EV/Sales LTM | x | 0.71 | 0.56 | ||||||
| Earnings Yield LTM | % | 4.15% | -4.45% | ||||||
| FCF Yield | % | -2.16% | 18.20% | ||||||
| Quality | |||||||||
| ROE | % | 3.60% | -2.66% | ||||||
| ROIC | % | 1.46% | 1.50% | ||||||
| Operating margin | % | 2.64% | 1.46% | ||||||
| Gross margin | % | 20.84% | 33.19% | ||||||
| FCF/Sales | % | -1.03% | 6.23% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | -28.65% | - | ||||||
| Sales Growth YoY | % | -4.76% | -8.88% | ||||||
| Net Income Growth YoY | % | -30.15% | - | ||||||
| FCF Growth | % | - | +2863.6% | ||||||
| Operating Profit Growth | % | -46.04% | -83.82% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 1.91% | 3.07% | ||||||
| Dividend Growth | % | +11.11% | +11.11% | ||||||
| Payout Ratio | % | 45.91% | -70.12% | ||||||
| FCF/Debt | x | -0.03 | 0.17 | ||||||
| Net Debt/EBITDA | x | 2.84 | 2.76 | ||||||
| EBIT/Net interest | x | 1.92 | 2.24 | ||||||
| Net debt/market cap | % | 43.47% | 65.13% | ||||||
| Net debt/Equity | x | 0.38 | 0.40 | ||||||
| Gross debt/equity | x | 0.67 | 0.65 | ||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Mayr-Melnhof Karton AG, together with its subsidiaries, manufactures and sells carton boards, paper, and folding cartons primarily in Europe. It operates through three segments: MM Food & Premium Packaging, MM Pharma & Healthcare Packaging, and MM Board & Paper. The MM Food & Premium segment processes carton boards into folding cartons primarily for the food industry and other consumer goods industries. The MM Pharma & Healthcare Packaging segment processes carton boards into folding cartons for the pharmaceutical industry, as well as leaflets and labels. The MM Board & Paper segment manufactures and markets carton boards focusing on coated carton board produced from recycled fibres, as well as virgin fibre-based carton boards. It also offers kraft papers, uncoated fine papers, and pulp. The company was founded in 1888 and is based in Vienna, Austria.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Mayr-Melnhof Karton AG (MMK.VI)
Based on consensus from external analysts. Not Kvantra's opinion.
Mayr-Melnhof Karton AG, together with its subsidiaries, manufactures and sells carton boards, paper, and folding cartons primarily in Europe. It operates through three segments: MM Food & Premium Packaging, MM Pharma & Healthcare Packaging, and MM Board & Paper. The MM Food & Premium segment processes carton boards into folding cartons primarily for the food industry and other consumer goods industries. The MM Pharma & Healthcare Packaging segment processes carton boards into folding cartons for the pharmaceutical industry, as well as leaflets and labels. The MM Board & Paper segment manufactures and markets carton boards focusing on coated carton board produced from recycled fibres, as well as virgin fibre-based carton boards. It also offers kraft papers, uncoated fine papers, and pulp. The company was founded in 1888 and is based in Vienna, Austria.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free